Prelude Therapeutics Incorporated (PRLD) Earnings
NASDAQ·Healthcare·Biotechnology
$4.20
-13.40%
Mkt Cap $261.32M
EPS — Estimate vs Actual
Mkt Cap
$261.32M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58
NASDAQ·Healthcare·Biotechnology
$4.20
-13.40%
Mkt Cap $261.32M
Mkt Cap
$261.32M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58